A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)

Name: A Study of the Safety and Efficacy of Omarigliptin (MK-3102) in ≥18 and <45 Year-Old Participants With Type 2 Diabetes Mellitus and Inadequate Glycemic Control (MK-3102-028)
License: Public Domain

Merck Sharp & Dohme LLC

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

diabetes-mellitus

diabetes mellitus

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 249560
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.